Shree Ganesh Remedies Limited (NSE:SGRL)

Shree Ganesh Remedies Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	919.58	1,093	1,086	1,259	902.2	712.88
Revenue Growth	-13.63%	0.64%	-13.74%	39.54%	26.56%	45.24%
Gross Profit Gross Profit Growth	562.57	638.56	694.57	676.52	425.74	339.77
Operating Income Operating Income Growth	162.63	258.27	307.58	363.12	204.78	150.72
Net Income Net Income Growth	121.09	177.6	230.68	281.08	170.2	133.99
Earnings Per Share EPS Growth	9.43	13.83	17.96	22.34	13.86	10.96
EPS Growth	-40.74%	-22.99%	-19.60%	61.17%	26.47%	34.91%

Revenue by Geography

Chart

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
India India Growth	460	415.1	555.98	283.6
Outside India Outside India Growth	632.86	670.87	692.04	-
Total Total Growth	1,093	1,086	1,248	902.2

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	287.74	258.74	282.3	205.12	111.5	38.83
Total Debt Total Debt Growth	261.39	308.13	383.84	364.49	335.07	-
Net Cash (Debt) Net Cash Growth	26.35	-49.39	-101.55	-159.37	-223.57	38.83
Net Cash Growth	-	-	-	-	-	-39.08%
Net Cash Per Share Net Cash Per Share Growth	2.05	-3.85	-7.91	-12.67	-18.21	3.18

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	207.19	237.42	306.64	304.49	170.11	134.17
Capital Expenditures CapEx Growth	-146.43	-165.98	-231.95	-311.38	-515.83	-153.28
Free Cash Flow Free Cash Flow Growth	60.76	71.44	74.69	-6.9	-345.72	-19.11
Free Cash Flow Growth	-46.78%	-4.35%	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	61.18%	58.43%	63.96%	53.74%	47.19%	47.66%
Operating Margin	17.69%	23.63%	28.32%	28.84%	22.70%	21.14%
Pretax Margin	17.94%	21.97%	28.79%	30.31%	25.03%	25.26%
Profit Margin	13.17%	16.25%	21.24%	22.33%	18.87%	18.80%
FCF Margin	6.61%	6.54%	6.88%	-0.55%	-38.32%	-2.68%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	64.57	30.36	39.58	30.30	18.20	26.58
P/FCF Ratio	128.37	75.48	122.25	-	-	-
PS Ratio	8.48	4.93	8.41	6.77	3.43	5.00

Data Source: S&P Global Market Intelligence Last updated: Oct 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error